Printer Friendly
The Free Library
19,595,263 articles and books
Member login
User name  
Password 
 
Join us Forgot password?

AntiCancer Inc. Develops Whole-Body Imaging of Tumor Angiogenesis.


Business Editors & Health/Medical Writers

BIOWIRE2K

SAN DIEGO--(BW HealthWire)--Feb. 26, 2001

AntiCancer Inc. scientists announced today that they have developed a new technology that enables angiogenesis, or blood vessel formation, in tumors to be non-invasively imaged in mouse models of cancer.

The technology involves genetically engineering tumor cells to become highly fluorescent by expressing the jellyfish jellyfish, common name for the free-swimming stage (see polyp and medusa), of certain invertebrate animals of the phylum Cnidaria (the coelenterates). The body of a jellyfish is shaped like a bell or umbrella, with a clear, jellylike material filling most of the  green fluorescent protein "EGFP" redirects here. EGFP may also refer to the ICAO airport code for Pembrey Airport.

The green fluorescent protein (GFP) is a protein, comprised of 238 amino acids (26,9 kDa), from the jellyfish Aequorea victoria
 (GFP GFP Green Fluorescent Protein
GFP Generic Framing Procedure
GFP Government Furnished Property
GFP Generic Frame Protocol
GFP General Framing Procedure
GFP Global Functional Plane
GFP Global Field Power
GFP Grandmothers for Peace
GFP Glutton for Punishment
). When the genetically fluorescent tumors are transplanted to appropriate mouse models, the tumor blood vessels, which originate from the host animals, are readily quantitatively whole-body imaged by their stark contrast to the fluorescent tumors. The mice are not perturbed per·turb  
tr.v. per·turbed, per·turb·ing, per·turbs
1. To disturb greatly; make uneasy or anxious.

2. To throw into great confusion.

3.
 in the imaging process -- only a blue light is shined on them causing the tumors to glow a bright green with the blood vessels appearing black. The fluorescent tumor models can then be used for drug discovery and evaluation in the worldwide effort to find drugs that are effective against tumor blood vessel formation. Attacking tumor angiogenesis is thought to be one of the most promising targets to arrest and reverse metastatic Metastatic
The term used to describe a secondary cancer, or one that has spread from one area of the body to another.

Mentioned in: Coagulation Disorders


metastatic

pertaining to or of the nature of a metastasis.
 tumor growth. AntiCancer's new angiogenesis model is described in the current issue of the Proceedings of the National Academy of Sciences The Proceedings of the National Academy of Sciences of the United States of America, usually referred to as PNAS, is the official journal of the United States National Academy of Sciences. , USA.

Dr. Shigeo Yagi ya·gi  
n. pl. ya·gis
A directional radio and television antenna consisting of a horizontal conductor with several insulated dipoles parallel to and in the plane of the conductor.
, general manager of AntiCancer said, "With AntiCancer's new development, there is, for the first time, a relevant and useful animal model of tumor angiogenesis. Tumor angiogenesis can now be followed non-invasively in real time by whole-body imaging. This should now enable efficient drug discovery in this critical process of tumor growth and metastasis." AntiCancer is currently utilizing its unique animal models of cancer to help pharmaceutical and biotechnology companies worldwide to discover and develop effective drugs for cancer.

AntiCancer, based in San Diego, has also developed whole-body fluorescent imaging technology to visualize tumor growth and metastasis non-invasively in mouse models. The company in addition is developing genetically-engineered cancer drugs; gene therapy for cancer and hair loss; as well as genetically-engineered diagnostics of cancer and cardiovascular disease through its A/C Diagnostics subsidiary. AntiCancer has 40 employees.
COPYRIGHT 2001 Business Wire
No portion of this article can be reproduced without the express written permission from the copyright holder.
Copyright 2001, Gale Group. All rights reserved. Gale Group is a Thomson Corporation Company.

 Reader Opinion

Title:

Comment:



 

Article Details
Printer friendly Cite/link Email Feedback
Publication:Business Wire
Geographic Code:1USA
Date:Feb 26, 2001
Words:334
Previous Article:Twentieth Century Fox and Bill Cosby Join Forces for 'Fat Albert' Live-Action Feature.
Next Article:General Magic Announces 'Voice' is The Killer App for Data.



Related Articles
Oxygen plays role in cancer aggressiveness.
Anticancer drugs: in vivo la difference!
Pummeling tumors with localized therapies.
THE QUIET 'WARRIOR' PIONEER IN CANCER RESEARCH PROFILED ON KCET'S 'NOVA'.
Tracking tumors: looking for early signs of a therapy's success.
Cancer drugs may also thwart obesity. (Fat Chance).
Dr. Folkman's War: Angiogenesis and the Struggle to Defeat Cancer. (Science News Books).
Rapamycin throws a Master switch. (Cancer).
Brain cancer patients short on valuable protein.
SANOFI-AVENTIS/REGENERON EXPAND VEGF TRAP PACT TO JAPAN.

Terms of use | Copyright © 2012 Farlex, Inc. | Feedback | For webmasters | Submit articles